Abstract
Alternative monotherapy and adjunctive therapy are both valid options following failure of initial monotherapy with an antiepileptic drug (AED). Depending on the cause of initial failure of AED monotherapy, one option may be favoured over the other. When proceeding with adjunctive therapy, considerations should include choosing an agent with a different mechanism of action to that of the existing antiepileptic drug and avoiding unfavourable pharmacokinetic interactions (e.g. those related to hepatic metabolism and enzyme induction).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abou-Khalil B. Selecting rational drug combinations in epilepsy. CNS Drugs. 2017;31(10):835–44.
Beghi E, Gatti G, Tonini C, et al. Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial. Epilepsy Res. 2003;57(1):1–13.
Kwan P, Brodie MJ. Epilepsy after the first drug fails: substitution or add-on? Seizure. 2000;9(7):464–8.
Millul A, Iudice A, Adami M, et al. Alternative monotherapy or add-on therapy in patients with epilepsy whose seizures do not respond to the first monotherapy: an Italian multicenter prospective observational study. Epilepsy Behav. 2013;28(3):494–500.
Semah F, Thomas P, Coulbaut S, et al. Early add-on treatment vs alternative monotherapy in patients with partial epilepsy. Epileptic Disord. 2014;16(2):165–74.
Canevini MP, De Sarro G, Galimberti CA, et al. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia. 2010;51(5):797–804.
Besag FM, Berry DJ, Pool F, et al. Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction? Epilepsia. 1998;39(2):183–7.
Margolis JM, Chu BC, Wang ZJ, et al. Effectiveness of antiepileptic drug combination therapy for partial-onset seizures based on mechanisms of action. JAMA Neurol. 2014;71(8):985–93.
Brodie MJ, Yuen AW, Group S. Lamotrigine substitution study: evidence for synergism with sodium valproate? Epilepsy Res. 1997;26(3):423–32.
Pisani F, Oteri G, Russo MF, et al. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction. Epilepsia. 1999;40(8):1141–6.
Funding
The preparation of this review was not supported by any external funding.
Author information
Authors and Affiliations
Consortia
Ethics declarations
Conflict of interest
The article was adapted from CNS Drugs 2017; 31(10):835–44 [1] by employees of Adis/Springer, who are responsible for the article content and declare no conflicts of interest.
Rights and permissions
About this article
Cite this article
Adis Medical Writers. Consider potential drug interactions when starting combination therapy with antiepileptic drugs. Drugs Ther Perspect 34, 368–371 (2018). https://doi.org/10.1007/s40267-018-0525-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40267-018-0525-z